FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2793230610> ?p ?o ?g. }

• W2793230610 endingPage "1018" @default.
• W2793230610 startingPage "1009" @default.
• W2793230610 abstract "Background Serum interleukin 6 (IL‐6), chemokine ligand 2 (CCL2), C‐reactive protein (CRP), and the ratio of aspartate transaminase to alanine transaminase (AST:ALT) have been correlated with fibrosis and necroinflammatory activity in humans with various hepatopathies. Hypothesis/Objectives To determine whether increases in serum IL‐6, CCL2, CRP, or AST:ALT were associated with moderate to severe fibrosis or necroinflammatory activity in dogs with various hepatopathies. Animals Forty‐four client‐owned dogs with clinical evidence of liver disease and 10 healthy purpose‐bred dogs, all undergoing liver biopsies by laparoscopy or laparotomy. Methods Measurement of serum IL‐6, CCL2, CRP, AST, and ALT before scheduled liver biopsy and evaluation of liver histopathology using the METAVIR scoring system used in human medicine, blinded to clinical presentation. Results Median serum IL‐6 was approximately twice as high in dogs with high fibrosis scores (15.5 pg/mL; range, 1.4 to 235 pg/mL) compared to dogs with low fibrosis scores (7.6 pg/mL; range, 1.4 to 148.1 pg/mL), with marginal significance ( P = .05). Median serum CCL2 was significantly higher in dogs with active necroinflammation (444 pg/mL; range, 144 to 896 pg/mL) compared to dogs without detectable necroinflammation (326 pg/mL; range, 59 to 1692 pg/mL; P = .008), but with considerable overlap between groups. Neither serum CRP nor AST:ALT ratios were significantly different based on fibrosis or necroinflammatory scores. Conclusions and Clinical Importance Because of substantial variability among dogs, single measurements of IL‐6 and CCL2 have limited diagnostic utility for identifying fibrosis or necroinflammation, respectively, in dogs with various chronic liver diseases. The value of these biomarkers should be explored further in monitoring response to treatment in individual dogs with chronic hepatopathies." @default.
• W2793230610 created "2018-03-29" @default.
• W2793230610 creator A5004693200 @default.
• W2793230610 creator A5034035357 @default.
• W2793230610 creator A5035329150 @default.
• W2793230610 creator A5070843492 @default.
• W2793230610 creator A5090797592 @default.
• W2793230610 date "2018-02-27" @default.
• W2793230610 modified "2023-10-18" @default.
• W2793230610 title "Evaluation of potential serum biomarkers of hepatic fibrosis and necroinflammatory activity in dogs with liver disease" @default.
• W2793230610 cites W1476233474 @default.
• W2793230610 cites W1499323592 @default.
• W2793230610 cites W1530817817 @default.
• W2793230610 cites W1583164105 @default.
• W2793230610 cites W1947813288 @default.
• W2793230610 cites W1968280843 @default.
• W2793230610 cites W1977662671 @default.
• W2793230610 cites W1996559225 @default.
• W2793230610 cites W1999931740 @default.
• W2793230610 cites W2002163127 @default.
• W2793230610 cites W2011321961 @default.
• W2793230610 cites W2012981996 @default.
• W2793230610 cites W2020195661 @default.
• W2793230610 cites W2022053538 @default.
• W2793230610 cites W2027590052 @default.
• W2793230610 cites W2034674595 @default.
• W2793230610 cites W2049938006 @default.
• W2793230610 cites W2054689641 @default.
• W2793230610 cites W2065192517 @default.
• W2793230610 cites W2074111219 @default.
• W2793230610 cites W2076709487 @default.
• W2793230610 cites W2081447181 @default.
• W2793230610 cites W2082719402 @default.
• W2793230610 cites W2084722601 @default.
• W2793230610 cites W2084776235 @default.
• W2793230610 cites W2088078852 @default.
• W2793230610 cites W2088332951 @default.
• W2793230610 cites W2089865834 @default.
• W2793230610 cites W2094174828 @default.
• W2793230610 cites W2106119616 @default.
• W2793230610 cites W2110463517 @default.
• W2793230610 cites W2112384358 @default.
• W2793230610 cites W2114505074 @default.
• W2793230610 cites W2117609334 @default.
• W2793230610 cites W2131916464 @default.
• W2793230610 cites W2135534248 @default.
• W2793230610 cites W2140789807 @default.
• W2793230610 cites W2147735994 @default.
• W2793230610 cites W2170161534 @default.
• W2793230610 cites W2170816166 @default.
• W2793230610 cites W2253819322 @default.
• W2793230610 cites W2290501114 @default.
• W2793230610 cites W2412931541 @default.
• W2793230610 cites W2418983811 @default.
• W2793230610 cites W2487315577 @default.
• W2793230610 cites W2522829286 @default.
• W2793230610 cites W2533227013 @default.
• W2793230610 cites W2536347035 @default.
• W2793230610 cites W2569515530 @default.
• W2793230610 cites W2603520335 @default.
• W2793230610 cites W2618889405 @default.
• W2793230610 cites W2735701646 @default.
• W2793230610 cites W49725469 @default.
• W2793230610 doi "https://doi.org/10.1111/jvim.15064" @default.
• W2793230610 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5980386" @default.
• W2793230610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29485210" @default.
• W2793230610 hasPublicationYear "2018" @default.
• W2793230610 type Work @default.
• W2793230610 sameAs 2793230610 @default.
• W2793230610 citedByCount "13" @default.
• W2793230610 countsByYear W27932306102019 @default.
• W2793230610 countsByYear W27932306102020 @default.
• W2793230610 countsByYear W27932306102021 @default.
• W2793230610 countsByYear W27932306102022 @default.
• W2793230610 countsByYear W27932306102023 @default.
• W2793230610 crossrefType "journal-article" @default.
• W2793230610 hasAuthorship W2793230610A5004693200 @default.
• W2793230610 hasAuthorship W2793230610A5034035357 @default.
• W2793230610 hasAuthorship W2793230610A5035329150 @default.
• W2793230610 hasAuthorship W2793230610A5070843492 @default.
• W2793230610 hasAuthorship W2793230610A5090797592 @default.
• W2793230610 hasBestOaLocation W27932306101 @default.
• W2793230610 hasConcept C126322002 @default.
• W2793230610 hasConcept C142724271 @default.
• W2793230610 hasConcept C160160445 @default.
• W2793230610 hasConcept C181199279 @default.
• W2793230610 hasConcept C185592680 @default.
• W2793230610 hasConcept C2775934546 @default.
• W2793230610 hasConcept C2777766500 @default.
• W2793230610 hasConcept C2778606649 @default.
• W2793230610 hasConcept C2779679107 @default.
• W2793230610 hasConcept C2780559512 @default.
• W2793230610 hasConcept C2780567839 @default.
• W2793230610 hasConcept C544855455 @default.
• W2793230610 hasConcept C55493867 @default.
• W2793230610 hasConcept C71924100 @default.
• W2793230610 hasConcept C90924648 @default.
• W2793230610 hasConceptScore W2793230610C126322002 @default.

• next